One of the traps for hybrids investors can fall into with any high yielding security which is past its call date is to buy it at more than its face value, only to have the issuer call it. Earlier this year Evans & Partners highlighted this issue. Using Ramsay Healthcare “CARES” (ASX code: RHCPA) as an example, E & P pointed out the way to avoid potentially-disappointing returns is to...